Article info

Download PDFPDF

Original article
Safety and maintenance of response for tofacitinib monotherapy and combination therapy in rheumatoid arthritis: an analysis of pooled data from open-label long-term extension studies

Authors

  1. Correspondence to Dr Liza Takiya; liza.takiya{at}pfizer.com
View Full Text

Citation

Fleischmann R, Wollenhaupt J, Takiya L, et al
Safety and maintenance of response for tofacitinib monotherapy and combination therapy in rheumatoid arthritis: an analysis of pooled data from open-label long-term extension studies

Publication history

  • Received May 4, 2017
  • Revision received October 17, 2017
  • Accepted October 21, 2017
  • First published December 18, 2017.
Online issue publication 
December 18, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.